SCHEMBL1089014

SCHEMBL1089014

Cc1ccc(S(=O)(=O)N2CCC(N3CCCC(Nc4nccc(N5CCCCCC5)n4)C3)CC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.55
KDM4E B2RXH2 3/20 0.55
HRH4 Q9H3N8 3/20 0.45
CXCR4 P61073 1/20 0.45
EBP Q15125 1/20 0.45
DHCR7 Q9UBM7 1/20 0.45
CYP2D6 P10635 1/20 0.43
CYP2C19 P33261 1/20 0.43
IKBKB O14920 5/20 0.43
NPC1 O15118 1/20 0.43
LMNA P02545 1/20 0.43
EPHX2 P34913 1/20 0.43
GBA1 P04062 1/20 0.42
GAA P10253 2/20 0.42
MAPK8 P45983 2/20 0.41
CHUK O15111 1/20 0.41
MAPK9 P45984 1/20 0.41
MAPK10 P53779 1/20 0.41
MAPK11 Q15759 1/20 0.41
MAPK14 Q16539 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1090079 0.98 ALDH1A1 (0.55) ALDH1A1KDM4EHRH4CXCR4EBP
SCHEMBL1090432 0.96 ALDH1A1 (0.53) ALDH1A1KDM4EHRH4CXCR4EBP
SCHEMBL1091333 0.92 HRH4 (0.47) ALDH1A1KDM4EHRH4CXCR4IKBKB
SCHEMBL1090290 0.91 HRH4 (0.48) ALDH1A1KDM4EHRH4CXCR4IKBKB
SCHEMBL1090475 0.91 ALDH1A1 (0.55) ALDH1A1KDM4EHRH4CXCR4CYP2D6
SCHEMBL1090389 0.91 KDM4E (0.54) ALDH1A1KDM4EHRH4CXCR4IKBKB
SCHEMBL1091184 0.91 ALDH1A1 (0.57) ALDH1A1KDM4EHRH4CXCR4CYP2D6
SCHEMBL1090247 0.91 EPHX2 (0.45) ALDH1A1KDM4EHRH4CXCR4CYP2D6
SCHEMBL1090612 0.90 EPHX2 (0.46) ALDH1A1KDM4EHRH4CXCR4EBP
SCHEMBL1090153 0.90 ALDH1A1 (0.55) ALDH1A1KDM4EHRH4CXCR4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 ALDH1A1 916/4885KDM4E 2001/4885HRH4 130/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 ALDH1A1 916/4885KDM4E 2001/4885HRH4 130/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 ALDH1A1 916/4885KDM4E 2001/4885HRH4 130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.